美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,249.79

-103.3901-7.64%

漲家數：1

跌家數：6

平家數：- -

市盈率：- -

高：1,362.19

開：1,356.11

低：1,242.41

收：1,353.23

資料載入中...

健康巡診：美國研究發現：乳腺癌對年輕女性的致命性正在降低

BUZZ-前瞻：安進公司收盤後盈利下滑

諾和諾德盤中異動早盤股價大漲2.87%報68.36美元

BUZZ-減肥藥銷售未達預期，禮來下跌

Haleon 預測中期利潤將以高個位數百分比增長

禮來淡化 CVS 放棄 Zepbound 保險的舉動，股價大跌

由於糖尿病藥物的強勁表現，禮來第一季度利潤超出預期

輝瑞4月30日成交額為13.08億美元

諾和諾德4月30日成交額為6.11億美元

77億美元，輝瑞又開始省錢了

安進4月30日成交額為7.58億美元

禮來漲1.69% 股價突破900美元大關

【歐股“十一羅漢”收盤播報｜4月份LVMH集團跌14.8%，諾和諾德跌約7.4%，歐萊雅則漲將近12.9%】週三，阿斯麥控股荷蘭阿姆斯特丹股價收跌0.43%，報582.50歐元，4月份累計下跌3.88%。諾和諾德哥本哈根股價收漲2.53%，報435.10，4月份累跌7.39%。

BUZZ-心臟病藥物銷售推動 BridgeBio 季度收入增長

碩迪生物盤中異動股價大漲5.00%報27.21美元

減肥藥“斷腕”、核心藥物承壓輝瑞（PFE.US）欲“買買買”加碼心臟代謝短板

減肥藥“斷腕”、核心藥物承壓輝瑞欲“買買買”加碼心臟代謝短板

諾和諾德CEO最新演講：成功來自於有選擇地建立核心能力，胰島素領域的下一個目標是……

輝瑞4月29日成交額為23.31億美元

諾和諾德4月29日成交額為7.09億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1249.8353,"timestamp":1746129581020,"preClose":1353.2255,"halted":0,"volume":70673985,"delay":0,"changeRate":-0.076403,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-103.390137,"latestTime":"05-01 15:59:59 EDT","open":1356.1058,"high":1362.19,"low":1242.4124,"amount":12175112263.289799,"amplitude":0.088513,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.487449,"peRate":36.838608,"turnoverRate":0.006687,"increases":1,"decrements":6,"flats":0,"marketCap":1337808361952,"floatMarketCap":1253009711712},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1362.19,"amplitude":0.088513,"preClose":1353.2255,"low":1242.4124,"pbRate":"10.487449","latestPrice":1249.7877,"volume":70776514,"delay":0,"open":1356.1058,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1291.0822,"twentyDayClose":1296.1409,"sixtyDayClose":1354.5123,"secType":"PLATE","market":"US","turnoverRate":0.006687,"peRate":36.838608,"marketCap":1337808361952,"floatMarketCap":1253009711712,"timestamp":1746129581501,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":1,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532884762","title":"健康巡診：美國研究發現：乳腺癌對年輕女性的致命性正在降低","url":"https://stock-news.laohu8.com/highlight/detail?id=2532884762","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532884762?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 03:20","pubTimestamp":1746127242,"startTime":"0","endTime":"0","summary":"今天，我们将介绍一项美国研究，该研究强调了年轻女性乳腺癌患者生存率的大幅提高。总体而言，该年龄组的乳腺癌死亡率从 2010 年的每 10 万名妇女中有 9.70 人死亡降至 2020 年的每 10 万名妇女中有 1.47 人死亡。这项研究并不是为了证明 GLP-1 药物导致房颤事件减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4S3R91Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU1061106388.HKD","LU1069344957.HKD","SG9999014914.USD","SGXZ57979304.SGD","LU2471134796.USD","LU1232071149.USD","LU0823416689.USD","LU0471298694.HKD","LU0106261372.USD","LU0882574139.USD","LU1291159041.SGD","LU2112291526.USD","LU0058720904.USD","LU0094547139.USD","LU0256863902.USD","IE0009355771.USD","LU2361044865.SGD","LU0820561818.USD","LU2361045086.USD","BK4599","LU1093756168.USD","LU1989771016.USD","IE00BK4W5L77.USD","SGXZ51526630.SGD","SG9999014906.USD","BK4588","BK4585","LU2237443382.USD","LU2324357040.USD","LU1280957306.USD","LU0109391861.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU2491050154.USD","LU0256863811.USD","LU2471134523.USD","SG9999001176.SGD","LU2461242641.AUD","LU2063271972.USD","LU2237438978.USD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU1868837136.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0061475181.USD","LU1551013342.USD"],"gpt_icon":1},{"id":"2532100044","title":"BUZZ-前瞻：安進公司收盤後盈利下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2532100044","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532100044?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 00:25","pubTimestamp":1746116740,"startTime":"0","endTime":"0","summary":"5月1日 - ** 安进公司AMGN.O在收盘后发布第一季度财报前下跌 2.6%，至 283.41 美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R91QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2242652126.USD","BK4139","LU0289739699.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4581","LU0058720904.USD","BK4588","LU1023059063.AUD","LU0868494617.USD","LU1983299246.USD","BK4585","IE00B4R5TH58.HKD","BK4566","BK4599","LU0122379950.USD","LU0889565916.HKD","SG9999001440.SGD","IE0009355771.USD","BK4533","AMGN","LU0109394709.USD","IE0002141913.USD","LU1571399168.USD","LU2112291526.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2532100385","title":"諾和諾德盤中異動 早盤股價大漲2.87%報68.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532100385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532100385?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 21:31","pubTimestamp":1746106277,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时31分，诺和诺德股票出现异动，股价大幅上涨2.87%。截至发稿，该股报68.36美元/股，成交量180.215万股，换手率0.04%，振幅0.71%。诺和诺德股票所在的制药行业中，整体跌幅为3.37%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。其中，阿斯利康重返销冠宝座，诺华大涨超20%。近日，各大跨国药企2024年财报陆续出炉，7家跨国药企在中国的营收也浮出水面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213119a46ef1d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213119a46ef1d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU1093756325.SGD","NVO","BK4532","BK4588","BK4585","LU0154236417.USD"],"gpt_icon":1},{"id":"2532877079","title":"BUZZ-減肥藥銷售未達預期，禮來下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2532877079","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532877079?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 19:58","pubTimestamp":1746100694,"startTime":"0","endTime":"0","summary":"5月1日 - ** 制药商礼来LLY.N股价盘前下跌4.3%至860.72美元 ** 流行减肥药Zepbound的第一季度销售额略低于  华尔街预期 ** Zepbound第一季度的销售额为23.1亿美元，而分析师的平均预期为23.3亿美元，数据由LSEG汇编。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R90XL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360106947.USD","IE00BQXX3F31.USD","LU0823416689.USD","LU2357305700.SGD","SG9999014914.USD","LU0079474960.USD","BK4534","LU0256863811.USD","LU2237443382.USD","LU0788108743.HKD","LU2471134879.HKD","LU0417517546.SGD","BK4516","LU1023059063.AUD","BK4007","BK4599","LU2602419157.SGD","LU2552382058.USD","LU0289961442.SGD","LU0109391861.USD","LU0385154629.USD","LU1551013425.SGD","LU2089984988.USD","LU2237443622.USD","IE00BJT1NW94.SGD","LU1019634622.SGD","LU1983299246.USD","LU0096364046.USD","LSEG.UK","LU1974910355.USD","SGXZ51526630.SGD","LLY","LU1051770623.HKD","LU0203202063.USD","LU1917777945.USD","LU0672654240.SGD","LU2491050071.SGD","LU1355424745.HKD","LU2471134523.USD","SG9999014898.SGD","LU0289739343.SGD","IE0009355771.USD","LU0006306889.USD","IE00BK4W5M84.HKD","LU0057025933.USD","LU1720051017.SGD","LU0887340254.USD","GB00BDT5M118.USD","LU2237443549.SGD","LU1003076772.USD"],"gpt_icon":1},{"id":"2532982076","title":"Haleon 預測中期利潤將以高個位數百分比增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2532982076","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532982076?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 19:42","pubTimestamp":1746099771,"startTime":"0","endTime":"0","summary":"更新版 2-Haleon 预测中期利润将以高个位数百分比增长预计五年内可节约 8 亿英镑的生产成本杰富瑞分析师预计 2027 年盈利共识将上调 5股价上涨近 4第 7、9 和 10 段增加了分析师评论，第 3 段更新了股价，第 6 段增加了前景细节Pushkala Aripaka. 路透5月1日 - 感康牙膏生产商海伦HLN.L周四预测，受主要市场对其产品的稳定需求和供应链成本削减预期的帮助，从2026年起其利润将实现高个位数百分比的增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R90VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BLSP4239.USD","LU1057294990.SGD","LU0234572021.USD","SG9999013999.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK5127","BK5011","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","LU0868494617.USD","BK4533","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","HLN.UK","LU1066053197.SGD"],"gpt_icon":1},{"id":"2532107857","title":"禮來淡化 CVS 放棄 Zepbound 保險的舉動，股價大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2532107857","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532107857?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 18:57","pubTimestamp":1746097025,"startTime":"0","endTime":"0","summary":"更新版 6-礼来淡化 CVS 放弃 Zepbound 保险的举动，股价大跌礼来首席执行官称受 CVS 迁移影响最大的企业是小雇主投资者称股票对 CVS 决定的反应 \"过于夸张礼来公司第一季度利润和收入高于华尔街预期重写第 2-5 段，加入首席执行官的评论，增加第 9 段 CVS 首席执行官，第 12 段 Zepbound 和 Wegovy 的销售预期Bhanvi Satija/Patrick Wingrove. 礼来公司的两位投资者表示，CVS 的承保决定将使诺和诺德与礼来公司之间的价格竞争白热化。该公司称，Zepbound 价格下降导致本季度收入减少，但需求依然强劲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R90RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1712237335.SGD","LU1983299246.USD","LU0109391861.USD","LU1093756168.USD","LU1720051108.HKD","LU2468319806.SGD","LU0471298694.HKD","LU1814569148.SGD","LU0417517546.SGD","IE00B1BXHZ80.USD","LU0320765059.SGD","LU0354030511.USD","LU2324357040.USD","LU2552382132.HKD","SGXZ31699556.SGD","LU0061475181.USD","LU1868837136.USD","LU0203201768.USD","LU0689472784.USD","LU2471134879.HKD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU0640476718.USD","LU1057294990.SGD","BK4585","LU2491050154.USD","LU0289739699.SGD","LU2491050071.SGD","IE00BJT1NW94.SGD","LLY","SG9999018865.SGD","LU2211815571.USD","LU2237438978.USD","IE00BK4W5M84.HKD","LU0106261372.USD","LU1232071149.USD","LU0820561909.HKD","LU2063271972.USD","LU0708995401.HKD","LU2361044865.SGD","LU0820561818.USD","LU1868836591.USD","LU2360106947.USD","LU0256863902.USD","LU1280957306.USD","LU0006306889.USD","LU1868836914.USD","BK4599","LU0882574139.USD"],"gpt_icon":1},{"id":"2532502076","title":"由於糖尿病藥物的強勁表現，禮來第一季度利潤超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2532502076","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532502076?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 18:47","pubTimestamp":1746096478,"startTime":"0","endTime":"0","summary":"由于糖尿病药物的强劲表现，礼来第一季度利润超出预期路透5月1日 - 礼来LLY.N周四公布的第一季度利润高于华尔街预期，这得益于其广受欢迎的减肥药和糖尿病药物Zepbound和Mounjaro的 强劲销售。  LSEG的数据显示 ，经调整后，这家美国 制药商本季度每股收益为3.34美元，而分析师预计为每股3.02美元。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R90Q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1267930730.SGD","LU2491050071.SGD","SG9999018865.SGD","SG9999015952.SGD","LU1366192091.USD","LU0203201768.USD","BK4534","LU0823416689.USD","LU2265009873.SGD","LU2237443895.HKD","LU1974910355.USD","LU0882574139.USD","BK4533","LU2237438978.USD","LU1093756168.USD","LU0471298777.SGD","SGXZ99366536.SGD","SG9999001176.USD","SGXZ51526630.SGD","LU0238689110.USD","BK4599","LLY","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1720051017.SGD","SG9999014880.SGD","GB00BDT5M118.USD","LU0943347566.SGD","LU2552382215.SGD","SGXZ57979304.SGD","LU0256863902.USD","LU0320765059.SGD","LU1280957306.USD","LU2357305700.SGD","LU2106854487.HKD","LU2552382132.HKD","LU0109391861.USD","LU1989771016.USD","LU2461242641.AUD","SG9999015986.USD","LU2552382058.USD","LU2491049909.HKD","LU2089984988.USD","LU2491050154.USD","LU0203202063.USD","LU0708995401.HKD","LU1720051108.HKD","LU0820561818.USD","LU0640476718.USD"],"gpt_icon":0},{"id":"2532904883","title":"輝瑞4月30日成交額為13.08億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532904883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532904883?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 10:22","pubTimestamp":1746066146,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，辉瑞成交额为13.08亿美元，成交额较昨日减少43.87%，当日成交量为5394.17万股。辉瑞于2025年4月30日涨2.61%，报24.41美元，该股过去5个交易日涨9.02%，年初至今跌6.47%，过去60日跌6.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|13.08亿|-43.87%|5394.17万|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0985481810.HKD","LU1066053197.SGD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0289739699.SGD","PFE","LU0868494617.USD","SG9999001176.USD","BK4599","LU1883839398.USD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","LU0122379950.USD","BK4550","BK4581","LU0058720904.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4534","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU1894683348.USD","SG9999002224.SGD","LU1057294990.SGD","BK4592","LU1066051498.USD","BK4007","SG9999002232.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4568","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2532048757","title":"諾和諾德4月30日成交額為6.11億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532048757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532048757?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 10:15","pubTimestamp":1746065752,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，诺和诺德成交额为6.11亿美元，成交额较昨日减少13.82%，当日成交量为924.29万股。诺和诺德于2025年4月30日涨1.98%，报66.45美元，该股过去5个交易日涨8.4%，年初至今跌21.71%，过去60日跌18.47%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501101556a6cf9014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501101556a6cf9014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU0154236417.USD","NVO","BK4532","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","BK4007","BK4585","BK4588"],"gpt_icon":1},{"id":"2532026633","title":"77億美元，輝瑞又開始省錢了","url":"https://stock-news.laohu8.com/highlight/detail?id=2532026633","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532026633?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 10:09","pubTimestamp":1746065340,"startTime":"0","endTime":"0","summary":"辉瑞公布2025年第一季度财报，总营收137亿美元，同比下降8%，主要原因是新冠药物Paxlovid销售额下降。研发费用支出也减少12%。辉瑞重申全年收入预计在610亿至640亿美元之间，并宣布新的成本削减计划，预计到2027年节省77亿美元开支。辉瑞通过自动化和人工智能等数字工具以及简化业务流程来实现成本节约，并计划从研发经费中砍掉5亿美元用于重新投资研发管线。在全球医药市场竞争激烈、成本压力上升的背景下，其他跨国药企如百时美施贵宝和赛诺菲也在实施大规模重组和裁员计划以降低成本。这些措施包括优化组织架构、减少层级、提高决策效率和整合职能，以应对行业挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","SG9999002232.USD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BK4581","LU0225771236.USD","IE00B19Z3581.USD","BK4592","BK4550","LU0868494617.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SG9999001176.USD","BK4533","SG9999001176.SGD","LU1066051498.USD","LU0306807586.USD","PFE","IE000M9KFDE8.USD","LU0985481810.HKD","LU0289739699.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999013999.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999011175.SGD","BK4007","LU1894683264.USD","BK4568","BK4599","SGXZ57979304.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0306806265.USD","LU1883839398.USD","BK4534","BK4585"],"gpt_icon":0},{"id":"2532901269","title":"安進4月30日成交額為7.58億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532901269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532901269?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 09:15","pubTimestamp":1746062159,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，安进成交额为7.58亿美元，成交额较昨日增加22.67%，当日成交量为261.23万股。安进于2025年4月30日涨0.82%，报290.92美元，该股过去5个交易日涨4.69%，年初至今涨12.52%，过去60日涨1.52%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091609a46e61e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091609a46e61e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001440.SGD","LU0868494617.USD","LU2242646821.SGD","BK4534","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU2242652126.USD","BK4599","LU0058720904.USD","BK4588","BK4585","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1061106388.HKD","BK4581","LU2468319806.SGD","AMGN","BK4566","IE00B2B36J28.USD","BK4533","LU0320765992.SGD","IE0002141913.USD","LU1571399168.USD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD","LU0889565916.HKD","LU0122379950.USD","LU0109394709.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2532806911","title":"禮來漲1.69% 股價突破900美元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2532806911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532806911?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 01:38","pubTimestamp":1746034712,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时38分，礼来股票出现异动，股价大幅拉升1.69%。截至发稿，该股报900.19美元/股，成交量166.674万股，换手率0.19%，振幅1.96%。最近的财报数据显示，该股实现营业收入450.43亿美元，净利润105.90亿美元，每股收益11.76美元，毛利366.24亿美元，市盈率76.81倍。礼来股票所在的制药行业中，整体涨幅为0.81%。其中，阿斯利康重返销冠宝座，诺华大涨超20%。近日，各大跨国药企2024年财报陆续出炉，7家跨国药企在中国的营收也浮出水面。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013835974bd002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013835974bd002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGXZ51526630.SGD","SG9999001176.USD","BK4599","SG9999014914.USD","SG9999014906.USD","LU2089984988.USD","BK4585","IE00B2B36J28.USD","LU2461242641.AUD","SG9999015945.SGD","LU1267930730.SGD","LU1720051108.HKD","IE00B1BXHZ80.USD","LU2237443465.HKD","LU1548497426.USD","LU0354030511.USD","LU2471134796.USD","LU2237443382.USD","SGXZ31699556.SGD","LU1366192091.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2471134952.CNY","LU1064131342.USD","LU2237443622.USD","LU0640476718.USD","LU0708995401.HKD","BK4534","LU2324357040.USD","LU1232071149.USD","LU1868837136.USD","LU1280957306.USD","LU0006306889.USD","LU2361044865.SGD","LU2750360641.GBP","LU0385154629.USD","LU0203201768.USD","LU1093756325.SGD","SG9999015978.USD","IE00BJLML261.HKD","LU0320765059.SGD","LU1868836914.USD","LU1983299246.USD","LLY","LU1974910355.USD","SGXZ57979304.SGD","LU0820561909.HKD","LU1623119135.USD","LU1868836757.USD","BK4516"],"gpt_icon":1},{"id":"2532066471","title":"【歐股“十一羅漢”收盤播報｜4月份LVMH集團跌14.8%，諾和諾德跌約7.4%，歐萊雅則漲將近12.9%】 週三，阿斯麥控股荷蘭阿姆斯特丹股價收跌0.43%，報582.50歐元，4月份累計下跌3.88%。諾和諾德哥本哈根股價收漲2.53%，報435.10，4月份累跌7.39%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532066471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532066471?lang=zh_tw&edition=fundamental","pubTime":"2025-05-01 01:17","pubTimestamp":1746033462,"startTime":"0","endTime":"0","summary":"周三，阿斯麦控股荷兰阿姆斯特丹股价收跌0.43%，报582.50欧元，4月份累计下跌3.88%。诺和诺德哥本哈根股价收涨2.53%，报435.10，4月份累跌7.39%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01011750063845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4599","03165","BK4007","LU0345774631.USD","BK4543","IE00BD6J9T35.USD","LU0154236417.USD","BK4147","LU0097036916.USD","NVO","LU1734074674.USD","IE0004445239.USD","LU0823434740.USD","BK4585","LU0823434583.USD","ASML","LU1093756325.SGD","BK4183","LU2063271972.USD","IE00BZ1G4Q59.USD","BK4588","LU0345774391.USD","IE00BKVL7J92.USD","LRLCY","LU1093756168.USD","BK4532"],"gpt_icon":0},{"id":"2531805210","title":"BUZZ-心臟病藥物銷售推動 BridgeBio 季度收入增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2531805210","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531805210?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 23:30","pubTimestamp":1746027047,"startTime":"0","endTime":"0","summary":"BUZZ-心脏病药物销售推动 BridgeBio 季度收入增长4月30日 - ** 制药公司BridgeBio Pharma BBIO.O股价上涨2.5%，至37.33美元。** 该公司的心脏病药物Attruby与Alnylam公司的ALNY.O Amvuttra和辉瑞公司的PFE.N Vyndamax形成竞争，该药物的季度销售额为3670万美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4T3R81WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","IE00BLSP4239.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4533","BK4599","LU0868494617.USD","LU1066051498.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU1894683264.USD","LU0321505868.SGD","LU1894683348.USD","LU0225284248.USD","LU1883839398.USD","SG9999002232.USD","BK4550","IE0002270589.USD","BBIO","LU0058720904.USD","LU1057294990.SGD","LU0122379950.USD","IE00BBT3K403.USD","SG9999001176.USD","BK4585","BK4139","BK4505","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999011175.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4548","SG9999013999.USD","ALNY","LU0985481810.HKD","LU0170899867.USD","LU1066053197.SGD","SG9999001176.SGD","LU0321505439.SGD","LU0234572021.USD","BK4592","LU1023059063.AUD","BK4581","LU0306806265.USD","LU0225771236.USD","BK4534","BK4007","LU0306807586.USD"],"gpt_icon":1},{"id":"2531052139","title":"碩迪生物盤中異動 股價大漲5.00%報27.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531052139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531052139?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 22:48","pubTimestamp":1746024495,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时48分，硕迪生物股票出现波动，股价快速上涨5.00%。截至发稿，该股报27.21美元/股，成交量45.9066万股，换手率0.80%，振幅6.72%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-11.49倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224815974bb277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224815974bb277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2531774147","title":"減肥藥“斷腕”、核心藥物承壓  輝瑞（PFE.US）欲“買買買”加碼心臟代謝短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774147?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞在2025年第一季度财报中披露，继口服减肥药Danuglipron研发受挫后，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。为应对业绩波动，辉瑞升级成本管控计划：在2025年底前实现45亿美元净成本节约的基础上，进一步追加12亿美元节省目标，预计到2027年底累计节省57亿美元。据了解，4月中旬，辉瑞宣布终止GLP-1受体激动剂Danuglipron的研发。辉瑞正面临核心管线断档与成本压力的双重挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","LU0225284248.USD","LU0456855351.SGD","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4599","IE0002270589.USD","LU1066053197.SGD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","BK4550","PFE","SG9999013999.USD","BK4007","LU1894683264.USD","LU0122379950.USD","LU0306806265.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0868494617.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","LU0225771236.USD","BK4588","LU0985481810.HKD","BK4568","SG9999002232.USD"],"gpt_icon":1},{"id":"2531312703","title":"減肥藥“斷腕”、核心藥物承壓輝瑞欲“買買買”加碼心臟代謝短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531312703","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531312703?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996220,"startTime":"0","endTime":"0","summary":"辉瑞在2025年第一季度财报中披露，由于口服减肥药Danuglipron研发受挫，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。尽管Q1营收未达预期，但调整后每股收益超预期，公司维持全年盈利指引上限。新冠产品表现不一，Paxlovid收入低于预期，而Comirnaty疫苗超出预期。核心药物如Eliquis销售额下滑。为应对业绩波动，辉瑞升级成本管控计划，预计到2027年底累计节省57亿美元。辉瑞CEO表示将通过内部研发和外部合作构建心脏代谢领域产品矩阵。分析师认为，通过收购或合作快速补充产品线是突破增长瓶颈的关键。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4239.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU1066053197.SGD","BK4534","LU1066051498.USD","SG9999001176.USD","LU0122379950.USD","BK4581","LU1894683348.USD","LU1894683264.USD","LU0321505868.SGD","BK4592","IE00BBT3K403.USD","BK4550","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4599","LU0306806265.USD","SG9999002232.USD","BK4585","SG9999013999.USD","LU0225284248.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999003800.SGD","SG9999011175.SGD","BK4588","LU1023059063.AUD","LU0306807586.USD","LU0456855351.SGD","BK4533","IE00BLSP4452.SGD","LU0170899867.USD","PFE","LU0321505439.SGD","LU0234572021.USD","BK4007","LU0058720904.USD","LU0868494617.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1883839398.USD","LU0225771236.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4568"],"gpt_icon":0},{"id":"2531702577","title":"諾和諾德CEO最新演講：成功來自於有選擇地建立核心能力，胰島素領域的下一個目標是……","url":"https://stock-news.laohu8.com/highlight/detail?id=2531702577","media":"IN咖","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531702577?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 13:19","pubTimestamp":1745990345,"startTime":"0","endTime":"0","summary":"而过去10个月，股价从高点140多美元跌至目前约65美元，已经腰斩。有选择地建立核心能力今天我们讨论的主题是：什么造就了伟大的企业。在诺和诺德，我们非常重视有选择地建立核心能力。这就回到使命本身：诺和诺德的使命是“驱动变革，战胜严重的慢性疾病”。换句话说，慢性病已经威胁到了各国医疗体系的可持续性。我们的最终目标，是将它制成口服药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430161806a46d6153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430161806a46d6153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD","NVO","BK4532","BK4599","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007"],"gpt_icon":1},{"id":"2531723794","title":"輝瑞4月29日成交額為23.31億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531723794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531723794?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 10:21","pubTimestamp":1745979667,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，辉瑞成交额为23.31亿美元，成交额较昨日增加80.85%，当日成交量为9854.02万股。辉瑞于2025年4月29日涨3.21%，报23.79美元，该股过去5个交易日涨5.59%，年初至今跌8.84%，过去60日跌10.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU0234572021.USD","LU1057294990.SGD","BK4534","PFE","IE00B19Z3581.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002224.SGD","BK4599","LU0289739699.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4588","BK4585","LU0306807586.USD","IE0002270589.USD","BK4533","BK4581","LU1883839398.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD","BK4550"],"gpt_icon":1},{"id":"2531472807","title":"諾和諾德4月29日成交額為7.09億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531472807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531472807?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 10:14","pubTimestamp":1745979274,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，诺和诺德成交额为7.09亿美元，成交额较昨日增加80.46%，当日成交量为1092.37万股。诺和诺德于2025年4月29日涨4.06%，报65.16美元，该股过去5个交易日涨8.76%，年初至今跌23.23%，过去60日跌21.78%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430101445a6ce2698&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430101445a6ce2698&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD","NVO","BK4532","BK4599","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123,"code":"91000000","status":"200"}]}}